Immunoglobulin A-mediated protection against Bordetella pertussis infection.
about
Overcoming the Constraints of Anti-HIV/CD89 Bispecific Antibodies That Limit Viral InhibitionT- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1 19).Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics.The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune CellsEnhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) bindingImpact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8.The role of the secretory immune response in the infection by Entamoeba histolytica.Pertussis: a matter of immune modulation.Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae.Immunoglobulin A: A next generation of therapeutic antibodies?Structure and function relationships in IgA.Immunity to the respiratory pathogen Bordetella pertussis.Targeting antigens to dendritic cell receptors for vaccine developmentLive attenuated vaccines against pertussis.T-cell immune responses to Bordetella pertussis infection and vaccination.Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophilsEndocytosis of FcalphaR is clathrin and dynamin dependent, but its cytoplasmic domain is not required.Monocyte CD64 or CD89 targeting by surfactant protein D/anti-Fc receptor mediates bacterial uptake.Comparative role of immunoglobulin A in protective immunity against the Bordetellae.Humoral immunity against Bordetella pertussis: antibodies or B cells?A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophils.Alternative splicing of myeloid IgA Fc receptor (Fc alpha R, CD89) transcripts in inflammatory responses.Establishment of a Bordetella avium challenge model in turkeys.Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs.
P2860
Q28831255-ABA70EF4-667D-46F2-93A4-D25142F00673Q33564283-C2D39CBA-10A5-4A74-A64A-2D65A025AF6CQ33725151-6E5A6086-8A71-45E6-98AD-74A4AE351EC7Q33738499-1B4BDF3E-6C54-4EF8-B935-10F7B53B2C26Q33968915-9F3B1E28-52A2-432A-9834-BDCA8AA1C148Q34066406-A357D916-1A80-4248-82EF-BF19B043AE55Q34081714-656FBFF9-22F1-4E89-9112-EE1BACE93FC1Q34218284-D3925AAB-2F08-46DB-8833-6D221FCE1FB4Q34499286-36A4A91B-DF23-494A-94F7-CFD2EB2172B9Q35312084-C2CF6B36-B11B-46FF-BD29-2EAD31E5504FQ35918232-1E536660-4EAF-445A-A306-0FE15D1B1DA7Q36155214-73FC1C48-23B1-4AF9-B88A-FF33EFBFF836Q36216363-6D1BF9A9-09B2-47FF-915A-7420A24FA362Q36487349-381E1A9B-B73A-4086-8940-AD571490DB4FQ36852188-D1894F87-9121-44D7-92F8-C69E42AB3BEFQ37825920-431226F7-7AB5-4744-A2EC-6ED94DD75C4AQ37862860-B8DA0DC5-F04F-4533-B04D-539C785CDFD5Q37892323-8DFC90F5-3F43-478B-8F53-79E8C9861EE6Q37936765-B9E4B8C4-F347-410D-BCFD-1481279475BAQ38020419-31156869-6B9D-414E-A412-59A7755CEE21Q38162446-2512BC7E-8CF8-45E9-925D-C44A5B8B5C8BQ38236200-3ED297D4-F655-4EE0-91C6-A42B66179E13Q38560699-00A177E0-8649-4B69-A099-56CF70EB2881Q39392681-74CCB57A-720A-4B10-9407-AB0C3F197CF4Q39783154-F3368B91-121B-433D-B3BD-507F0CCA46F1Q40300686-87D0BD5A-AF4F-4361-B4EC-BCABDB3C4A5CQ42413095-2E29ECB5-E9B3-4154-9A0E-A18686E36BA7Q42973845-175D57D8-4C6C-40E6-BFA9-1F0145ACF3F3Q43112430-7A7804CF-0B76-47B3-A003-03965572499BQ44298231-875ED866-9C58-404A-98D1-1CCAC5BB9922Q47703132-FB9684BD-1856-4CAC-9D6B-880A26BEBFF3Q47980043-1CC48D08-BF1C-4BA5-8566-B6B7989EEEA8
P2860
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@ast
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@en
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@nl
type
label
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@ast
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@en
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@nl
prefLabel
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@ast
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@en
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@nl
P2093
P2860
P1476
Immunoglobulin A-mediated protection against Bordetella pertussis infection.
@en
P2093
A B van Spriel
J F Schellekens
J G van de Winkel
S M Hellwig
P2860
P304
P356
10.1128/IAI.69.8.4846-4850.2001
P407
P577
2001-08-01T00:00:00Z